Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | CCR1 | P32246 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | CCR5 | P51681 | 1/20 | 0.40 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.39 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | GFER | P55789 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.35 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23891909 | 0.84 | KDM4E (0.41) | KDM4EALDH1A1HPGDUSP2HSD17B10 | |
| SCHEMBL15211700 | 0.84 | KDM4E (0.55) | KDM4EALDH1A1HPGDUSP2HSD17B10 | |
| SCHEMBL24589147 | 0.83 | KDM4E (0.41) | KDM4EALDH1A1HPGDUSP2HSD17B10 | |
| SCHEMBL6224336 | 0.82 | CYP19A1 (0.46) | KDM4EALDH1A1HPGDUSP2HSD17B10 | |
| SCHEMBL20038441 | 0.81 | KDM4E (0.38) | KDM4EALDH1A1HPGDUSP2HSD17B10 | |
| SCHEMBL19966840 | 0.80 | KCNH2 (0.43) | KDM4EALDH1A1HSD17B10TDP1MEN1 | |
| SCHEMBL23565851 | 0.80 | KDM4E (0.37) | KDM4EALDH1A1HPGDUSP2HSD17B10 | |
| SCHEMBL7573152 | 0.80 | CCR1 (0.40) | KDM4EALDH1A1HPGDUSP2HSD17B10 | |
| SCHEMBL30585580 | 0.80 | CCR1 (0.40) | KDM4EALDH1A1HPGDUSP2HSD17B10 | |
| SCHEMBL7118882 | 0.78 | PSMB5 (0.38) | KDM4EALDH1A1HPGDHSD17B10RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9209408-B2 | Organic compound, benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using the benzoxazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-12-08 | — | — | US | disclosed |
| US-20130261304-A1 | Organic Compound, Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Benzoxazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-10-03 | — | — | US | disclosed |
| US-8450485-B2 | Organic compound, benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using benzoxazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-05-28 | — | — | US | disclosed |
| US-20120178933-A1 | Organic Compound, Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-07-12 | — | — | US | disclosed |
| US-8142911-B2 | Organic compound, benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using the benzoxazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-03-27 | — | — | US | disclosed |
| US-20090284142-A1 | Organic Compound, Benzoxazole Derivative, and Light-Emitting Element, light-Emitting Device, and Electronic Device Using the Benzoxazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-11-19 | — | — | US | disclosed |
| EP-0088707-A1 | 2,7-Polyalkylnaphthyridines and process for their preparation | RHONE-POULENC S.A. (FR) | 1983-09-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120178933-A1 | Organic Compound, Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative | XDH, CYP2C9, CYP4X1 | KDM4E 2282/4885ALDH1A1 163/4885HPGD 567/4885 |
| US-20090284142-A1 | Organic Compound, Benzoxazole Derivative, and Light-Emitting Element, light-Emitting Device, and Electronic Device Using the Benzoxazole Derivative | XDH, CYP2C9, CYP4X1 | KDM4E 2122/4885ALDH1A1 172/4885HPGD 749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.